Lantus (insulin glargine) is a long-acting insulin that provides a steady, low level of insulin over a full 24 hours, mimicking the background insulin your pancreas would normally release between meals and overnight. It works through a clever chemical trick: the liquid in the pen or vial is slightly acidic, keeping the insulin fully dissolved. Once injected under your skin, where the pH is neutral, the insulin forms tiny solid clusters called microprecipitates. These clusters dissolve slowly and continuously, releasing small amounts of insulin into your bloodstream throughout the day with no pronounced peak.
What Happens After You Inject
The Lantus solution sits at a pH of about 4.0, which is acidic enough to keep insulin glargine completely dissolved. Your body’s tissue, by contrast, has a neutral pH around 7.4. That mismatch is intentional. The moment the acidic solution meets neutral tissue, insulin glargine becomes far less soluble and clumps into microscopic solid particles just beneath the skin. Think of it as a tiny depot or reservoir that your body draws from gradually.
From that depot, small amounts of insulin glargine break free and enter the bloodstream at a relatively constant rate. This slow, even release is what gives Lantus its flat activity profile. Unlike older basal insulins that spike a few hours after injection and then trail off, Lantus delivers a more uniform level of insulin, which more closely resembles the way a healthy pancreas drips out background insulin all day.
Onset, Peak, and Duration
Lantus takes about 3 to 4 hours to start lowering blood sugar after injection. It has no true peak, meaning there’s no point during the day when it’s working dramatically harder than any other point. Its glucose-lowering effect lasts up to 24 hours, which is why most people inject it once daily at the same time each day. The flat, peakless profile is a major practical advantage: it reduces the risk of blood sugar dropping unexpectedly in the middle of the night or between meals.
Why It Causes Less Low Blood Sugar Than Older Insulins
Before Lantus, the standard long-acting insulin was NPH, which has a noticeable peak roughly 4 to 8 hours after injection. That peak means NPH pushes blood sugar down more aggressively at certain hours, especially overnight, raising the risk of hypoglycemia while you sleep. In a meta-analysis of four randomized trials in people with type 2 diabetes, insulin glargine reduced the risk of severe hypoglycemia by 46% compared to NPH, and severe nocturnal hypoglycemia by 59%. Even among patients who reached tighter blood sugar targets (A1C at or below 7%), those on glargine had lower rates of nighttime lows than those on NPH (39% vs. 49%).
How Lantus Fits Into a Diabetes Regimen
Lantus covers your baseline insulin needs, the steady background supply that keeps blood sugar from rising when you’re not eating. It does not cover the spikes that happen after meals. People with type 1 diabetes pair Lantus with a rapid-acting insulin taken before each meal. People with type 2 diabetes may use Lantus alone (often alongside oral medications) or add mealtime insulin later if needed.
Lantus is approved for adults with type 1 or type 2 diabetes and for children aged 6 and older with type 1 diabetes.
Typical Starting Doses and Adjustments
If you’re starting Lantus for type 2 diabetes, a common approach is to begin at 10 units once daily, or to calculate a dose based on body weight. For someone whose A1C is below 8%, that’s typically 0.1 to 0.2 units per kilogram of body weight per day. For an A1C above 8%, the range moves to 0.2 to 0.3 units per kilogram.
From there, the dose gets fine-tuned based on your fasting blood sugar readings over several consecutive days. Adjustments usually happen every two to four days. The changes are small and methodical: if your fasting readings are running between 140 and 159 mg/dL, for example, you’d add 4 units. If they’re between 120 and 139, you’d add 2 units. If fasting numbers fall into the 80 to 99 range, the dose stays put. And if readings dip below 60, the dose drops by 4 units. This gradual titration lets you zero in on the right dose without overshooting into hypoglycemia.
Storage After Opening
Unopened Lantus pens and vials should be kept in the refrigerator. Once you start using a pen or vial, it can stay at room temperature (between 59°F and 86°F) for up to 28 days and still work effectively. After 28 days at room temperature, discard it even if insulin remains. Avoid exposing it to extreme heat, direct sunlight, or freezing temperatures, all of which can break down the insulin and make it less effective.
Biosimilar Alternatives
Lantus is the original brand of insulin glargine, but several biosimilar versions now exist. Basaglar contains the same insulin glargine molecule and works identically. Semglee (insulin glargine-yfgn) went a step further, becoming the first insulin biosimilar to receive an “interchangeable” designation from the FDA. That distinction means a pharmacist can substitute Semglee for Lantus without needing approval from the prescriber, similar to how generic drugs replace brand-name medications. The interchangeable versions offer the same mechanism, the same duration, and the same peakless profile at a lower cost.